Ticker Symbol: CERE
Cerevel Therapeutics Holdings Inc
$38.18 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001805387
Company Profile
cerevel therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (cns). the company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of cns disorders, including parkinson’s, alzheimer’s, epilepsy, schizophrenia and addiction. headquartered in the greater boston area, cerevel was formed in 2018 through a partnership between bain capital and pfizer.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 222 Jacobs Street
Website: cerevel.com
CEO: Anthony Coles Jr.
Tags:
- Finance
- Financial Conglomerates
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $22.75
Change:
-$0.02
(
-0.09%)
Days Range: $22.50 - $23.18
Beta: 1.32
52wk. High: $35.97
52wk. Low: $19.59
Ytd. Change -27.89%
50 Day Moving Average: $22.19
200 Day Moving Average: $27.27
Shares Outstanding: 157487636
Valuation
Market Cap: 358.3B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A